<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-10-01" modified="2020-10-07" version="242">
<accession>Q03164</accession>
<accession>E9PQG7</accession>
<accession>Q13743</accession>
<accession>Q13744</accession>
<accession>Q14845</accession>
<accession>Q16364</accession>
<accession>Q59FF2</accession>
<accession>Q6UBD1</accession>
<accession>Q9HBJ3</accession>
<accession>Q9UD94</accession>
<accession>Q9UMA3</accession>
<name>KMT2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone-lysine N-methyltransferase 2A</fullName>
<shortName>Lysine N-methyltransferase 2A</shortName>
<ecNumber evidence="45 56 70">2.1.1.354</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="77">ALL-1</fullName>
</alternativeName>
<alternativeName>
<fullName>CXXC-type zinc finger protein 7</fullName>
</alternativeName>
<alternativeName>
<fullName>Myeloid/lymphoid or mixed-lineage leukemia</fullName>
</alternativeName>
<alternativeName>
<fullName>Myeloid/lymphoid or mixed-lineage leukemia protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Trithorax-like protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger protein HRX</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>MLL cleavage product N320</fullName>
</recommendedName>
<alternativeName>
<fullName>N-terminal cleavage product of 320 kDa</fullName>
<shortName>p320</shortName>
</alternativeName>
</component>
<component>
<recommendedName>
<fullName>MLL cleavage product C180</fullName>
</recommendedName>
<alternativeName>
<fullName>C-terminal cleavage product of 180 kDa</fullName>
<shortName>p180</shortName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">KMT2A</name>
<name type="synonym">ALL1</name>
<name type="synonym">CXXC7</name>
<name type="synonym">HRX</name>
<name type="synonym">HTRX</name>
<name type="synonym">MLL</name>
<name type="synonym">MLL1</name>
<name type="synonym">TRX1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Cell" volume="71" first="691" last="700">
<title>Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.</title>
<authorList>
<person name="Tkachuk D.C."/>
<person name="Kohler S."/>
<person name="Cleary M.L."/>
</authorList>
<dbReference type="PubMed" id="1423624"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90602-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Br. J. Haematol." volume="93" first="966" last="972">
<title>Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias.</title>
<authorList>
<person name="Nilson I."/>
<person name="Loechner K."/>
<person name="Siegler G."/>
<person name="Greil J."/>
<person name="Beck J.D."/>
<person name="Fey G.H."/>
<person name="Marschalek R."/>
</authorList>
<dbReference type="PubMed" id="8703835"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.1996.d01-1748.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 3)</scope>
<scope>VARIANT GLY-30</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS VAL-53; LYS-502; THR-2319; ARG-2354; ARG-2387; ILE-3714 AND ALA-3773</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="2617" last="2625">
<title>Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.</title>
<authorList>
<person name="Yamamoto K."/>
<person name="Seto M."/>
<person name="Komatsu H."/>
<person name="Iida S."/>
<person name="Akao Y."/>
<person name="Kojima S."/>
<person name="Kodera Y."/>
<person name="Nakazawa S."/>
<person name="Ariyoshi Y."/>
<person name="Takahashi T."/>
<person name="Ueda R."/>
</authorList>
<dbReference type="PubMed" id="8378076"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-1909</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1992" name="Cell" volume="71" first="701" last="708">
<title>The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.</title>
<authorList>
<person name="Gu Y."/>
<person name="Nakamura T."/>
<person name="Alder H."/>
<person name="Prasad R."/>
<person name="Canaani O."/>
<person name="Cimino G."/>
<person name="Croce C.M."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="1423625"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90603-a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 63-3969 (ISOFORM 3)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH AFF1/MLLT2</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens protein coding cDNA.</title>
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 812-3969</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Nat. Genet." volume="2" first="113" last="118">
<title>A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias.</title>
<authorList>
<person name="Djabali M."/>
<person name="Selleri L."/>
<person name="Parry P."/>
<person name="Bower M."/>
<person name="Young B.D."/>
<person name="Evans G.A."/>
</authorList>
<dbReference type="PubMed" id="1303259"/>
<dbReference type="DOI" id="10.1038/ng1092-113"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1112-1140 AND 1552-162</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1317-2328</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Nat. Genet." volume="4" first="431" last="431">
<authorList>
<person name="Djabali M."/>
<person name="Selleri L."/>
<person name="Parry P."/>
<person name="Bower M."/>
<person name="Young B."/>
<person name="Evans G.A."/>
</authorList>
<dbReference type="PubMed" id="8401594"/>
<dbReference type="DOI" id="10.1038/ng0893-431"/>
</citation>
<scope>ERRATUM OF PUBMED:1303259</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Br. J. Haematol." volume="90" first="308" last="320">
<title>Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;11).</title>
<authorList>
<person name="Marschalek R."/>
<person name="Greil J."/>
<person name="Lochner K."/>
<person name="Nilson I."/>
<person name="Siegler G."/>
<person name="Zweckbronner I."/>
<person name="Beck J.D."/>
<person name="Fey G.H."/>
</authorList>
<dbReference type="PubMed" id="7794749"/>
<dbReference type="DOI" id="10.1111/j.1365-2141.1995.tb05151.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1212-1603 (ISOFORM 3)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="DNA Cell Biol." volume="14" first="475" last="483">
<title>The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing.</title>
<authorList>
<person name="Mbangkollo D."/>
<person name="Burnett R."/>
<person name="McCabe N."/>
<person name="Thirman M."/>
<person name="Gill H."/>
<person name="Yu H."/>
<person name="Rowley J.D."/>
<person name="Diaz M.O."/>
</authorList>
<dbReference type="PubMed" id="7598802"/>
<dbReference type="DOI" id="10.1089/dna.1995.14.475"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1251-1654 (ISOFORM 2)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="Cancer Res." volume="54" first="2327" last="2330">
<title>Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia.</title>
<authorList>
<person name="Gu Y."/>
<person name="Alder H."/>
<person name="Nakamura T."/>
<person name="Schichman S.A."/>
<person name="Prasad R."/>
<person name="Canaani O."/>
<person name="Saito H."/>
<person name="Croce C.M."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="8162575"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1251-1538</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="2814" last="2819">
<title>Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.</title>
<authorList>
<person name="Megonigal M.D."/>
<person name="Cheung N.-K.V."/>
<person name="Rappaport E.F."/>
<person name="Nowell P.C."/>
<person name="Wilson R.B."/>
<person name="Jones D.H."/>
<person name="Addya K."/>
<person name="Leonard D.G.B."/>
<person name="Kushner B.H."/>
<person name="Williams T.M."/>
<person name="Lange B.J."/>
<person name="Felix C.A."/>
</authorList>
<dbReference type="PubMed" id="10706619"/>
<dbReference type="DOI" id="10.1073/pnas.050397097"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1311-1687 (ISOFORM 3)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH GAS7</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="3157" last="3160">
<title>A method for identifying genes within yeast artificial chromosomes: application to isolation of MLL fusion cDNAs from acute leukaemia translocations.</title>
<authorList>
<person name="Forster A."/>
<person name="Rabbitts T.H."/>
</authorList>
<dbReference type="PubMed" id="8414518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1421-1540</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="186" last="194">
<title>Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.</title>
<authorList>
<person name="Hsieh J.J.-D."/>
<person name="Ernst P."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Korsmeyer S.J."/>
</authorList>
<dbReference type="PubMed" id="12482972"/>
<dbReference type="DOI" id="10.1128/mcb.23.1.186-194.2003"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2719-2730</scope>
<scope>CLEAVAGE</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 2718-ASP--VAL-2720</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="Oncogene" volume="13" first="2121" last="2130">
<title>Fusion of the MLL gene with two different genes, AF-6 and AF-5alpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia.</title>
<authorList>
<person name="Taki T."/>
<person name="Hayashi Y."/>
<person name="Taniwaki M."/>
<person name="Seto M."/>
<person name="Ueda R."/>
<person name="Hanada R."/>
<person name="Suzukawa K."/>
<person name="Yokota J."/>
<person name="Morishita K."/>
</authorList>
<dbReference type="PubMed" id="8950979"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH CENPK</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="Blood" volume="92" first="1125" last="1130">
<title>ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).</title>
<authorList>
<person name="Taki T."/>
<person name="Shibuya N."/>
<person name="Taniwaki M."/>
<person name="Hanada R."/>
<person name="Morishita K."/>
<person name="Bessho F."/>
<person name="Yanagisawa M."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="9694699"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ABI1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Nat. Genet." volume="18" first="331" last="337">
<title>Association of SET domain and myotubularin-related proteins modulates growth control.</title>
<authorList>
<person name="Cui X."/>
<person name="De Vivo I."/>
<person name="Slany R."/>
<person name="Miyamoto A."/>
<person name="Firestein R."/>
<person name="Cleary M.L."/>
</authorList>
<dbReference type="PubMed" id="9537414"/>
<dbReference type="DOI" id="10.1038/ng0498-331"/>
</citation>
<scope>INTERACTION WITH SBF1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="7050" last="7060">
<title>Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins.</title>
<authorList>
<person name="Adler H.T."/>
<person name="Chinery R."/>
<person name="Wu D.Y."/>
<person name="Kussick S.J."/>
<person name="Payne J.M."/>
<person name="Fornace A.J. Jr."/>
<person name="Tkachuk D.C."/>
</authorList>
<dbReference type="PubMed" id="10490642"/>
<dbReference type="DOI" id="10.1128/mcb.19.10.7050"/>
</citation>
<scope>INTERACTION WITH PPP1R15A</scope>
<scope>DISEASE</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="14535" last="14540">
<title>AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).</title>
<authorList>
<person name="Taki T."/>
<person name="Kano H."/>
<person name="Taniwaki M."/>
<person name="Sako M."/>
<person name="Yanagisawa M."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="10588740"/>
<dbReference type="DOI" id="10.1073/pnas.96.25.14535"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH AFF4</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Blood" volume="95" first="1066" last="1068">
<title>Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11)(p21;q23).</title>
<authorList>
<person name="Sano K."/>
<person name="Hayakawa A."/>
<person name="Piao J.-H."/>
<person name="Kosaka Y."/>
<person name="Nakamura H."/>
</authorList>
<dbReference type="PubMed" id="10648423"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCKIPSD/AF3P21</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="Blood" volume="96" first="4360" last="4362">
<title>t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (guanosine 5-prime monophosphate synthetase) gene.</title>
<authorList>
<person name="Pegram L.D."/>
<person name="Megonigal M.D."/>
<person name="Lange B.J."/>
<person name="Nowell P.C."/>
<person name="Rowley J.D."/>
<person name="Rappaport E.F."/>
<person name="Felix C.A."/>
</authorList>
<dbReference type="PubMed" id="11110714"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH GMPS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Genes Chromosomes Cancer" volume="31" first="382" last="389">
<title>Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).</title>
<authorList>
<person name="Daheron L."/>
<person name="Veinstein A."/>
<person name="Brizard F."/>
<person name="Drabkin H."/>
<person name="Lacotte L."/>
<person name="Guilhot F."/>
<person name="Larsen C.J."/>
<person name="Brizard A."/>
<person name="Roche J."/>
</authorList>
<dbReference type="PubMed" id="11433529"/>
<dbReference type="DOI" id="10.1002/gcc.1157"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH LPP</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="4075" last="4080">
<title>LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).</title>
<authorList>
<person name="Ono R."/>
<person name="Taki T."/>
<person name="Taketani T."/>
<person name="Taniwaki M."/>
<person name="Kobayashi H."/>
<person name="Hayashi Y."/>
</authorList>
<dbReference type="PubMed" id="12124344"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TET1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Mol. Cell" volume="10" first="1119" last="1128">
<title>ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.</title>
<authorList>
<person name="Nakamura T."/>
<person name="Mori T."/>
<person name="Tada S."/>
<person name="Krajewski W."/>
<person name="Rozovskaia T."/>
<person name="Wassell R."/>
<person name="Dubois G."/>
<person name="Mazo A."/>
<person name="Croce C.M."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="12453419"/>
<dbReference type="DOI" id="10.1016/s1097-2765(02)00740-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Cell" volume="115" first="293" last="303">
<title>Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.</title>
<authorList>
<person name="Hsieh J.J.-D."/>
<person name="Cheng E.H.-Y."/>
<person name="Korsmeyer S.J."/>
</authorList>
<dbReference type="PubMed" id="14636557"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00816-x"/>
</citation>
<scope>CLEAVAGE</scope>
<scope>INTERACTION WITH TASP1</scope>
<scope>MUTAGENESIS OF 2666-ASP-GLY-2667 AND 2718-ASP--VAL-2720</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="1400" last="1410">
<title>A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.</title>
<authorList>
<person name="Chinwalla V."/>
<person name="Chien A."/>
<person name="Odero M."/>
<person name="Neilly M.B."/>
<person name="Zeleznik-Le N.J."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="12618766"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206273"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ZFYVE19 AND KNL1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="1418" last="1424">
<title>Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14).</title>
<authorList>
<person name="Kuefer M.U."/>
<person name="Chinwalla V."/>
<person name="Zeleznik-Le N.J."/>
<person name="Behm F.G."/>
<person name="Naeve C.W."/>
<person name="Rakestraw K.M."/>
<person name="Mukatira S.T."/>
<person name="Raimondi S.C."/>
<person name="Morris S.W."/>
</authorList>
<dbReference type="PubMed" id="12618768"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206272"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH KNL1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Genes Chromosomes Cancer" volume="39" first="324" last="334">
<title>Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.</title>
<authorList>
<person name="von Bergh A.R.M."/>
<person name="Wijers P.M."/>
<person name="Groot A.J."/>
<person name="van Zelderen-Bhola S."/>
<person name="Falkenburg J.H.F."/>
<person name="Kluin P.M."/>
<person name="Schuuring E."/>
</authorList>
<dbReference type="PubMed" id="14978793"/>
<dbReference type="DOI" id="10.1002/gcc.20004"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH DAB2IP</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Leukemia" volume="18" first="998" last="1005">
<title>FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).</title>
<authorList>
<person name="Kojima K."/>
<person name="Sakai I."/>
<person name="Hasegawa A."/>
<person name="Niiya H."/>
<person name="Azuma T."/>
<person name="Matsuo Y."/>
<person name="Fujii N."/>
<person name="Tanimoto M."/>
<person name="Fujita S."/>
</authorList>
<dbReference type="PubMed" id="14999297"/>
<dbReference type="DOI" id="10.1038/sj.leu.2403334"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH SEPT11</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5639" last="5649">
<title>Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.</title>
<authorList>
<person name="Yokoyama A."/>
<person name="Wang Z."/>
<person name="Wysocka J."/>
<person name="Sanyal M."/>
<person name="Aufiero D.J."/>
<person name="Kitabayashi I."/>
<person name="Herr W."/>
<person name="Cleary M.L."/>
</authorList>
<dbReference type="PubMed" id="15199122"/>
<dbReference type="DOI" id="10.1128/mcb.24.13.5639-5649.2004"/>
</citation>
<scope>IDENTIFICATION IN THE MLL1/MLL COMPLEX</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="6521" last="6525">
<title>AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.</title>
<authorList>
<person name="Hayette S."/>
<person name="Cornillet-Lefebvre P."/>
<person name="Tigaud I."/>
<person name="Struski S."/>
<person name="Forissier S."/>
<person name="Berchet A."/>
<person name="Doll D."/>
<person name="Gillot L."/>
<person name="Brahim W."/>
<person name="Delabesse E."/>
<person name="Magaud J.-P."/>
<person name="Rimokh R."/>
</authorList>
<dbReference type="PubMed" id="16061630"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-1325"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FRYL</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Cell" volume="121" first="873" last="885">
<title>Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.</title>
<authorList>
<person name="Dou Y."/>
<person name="Milne T.A."/>
<person name="Tackett A.J."/>
<person name="Smith E.R."/>
<person name="Fukuda A."/>
<person name="Wysocka J."/>
<person name="Allis C.D."/>
<person name="Chait B.T."/>
<person name="Hess J.L."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="15960975"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.04.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE MLL1/MLL COMPLEX</scope>
<scope>INTERACTION WITH KAT8</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Genomics" volume="89" first="756" last="768">
<title>Nine-amino-acid transactivation domain: establishment and prediction utilities.</title>
<authorList>
<person name="Piskacek S."/>
<person name="Gregor M."/>
<person name="Nemethova M."/>
<person name="Grabner M."/>
<person name="Kovarik P."/>
<person name="Piskacek M."/>
</authorList>
<dbReference type="PubMed" id="17467953"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2007.02.003"/>
</citation>
<scope>DOMAIN 9AATAD</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="20395" last="20406">
<title>PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.</title>
<authorList>
<person name="Cho Y.-W."/>
<person name="Hong T."/>
<person name="Hong S."/>
<person name="Guo H."/>
<person name="Yu H."/>
<person name="Kim D."/>
<person name="Guszczynski T."/>
<person name="Dressler G.R."/>
<person name="Copeland T.D."/>
<person name="Kalkum M."/>
<person name="Ge K."/>
</authorList>
<dbReference type="PubMed" id="17500065"/>
<dbReference type="DOI" id="10.1074/jbc.m701574200"/>
</citation>
<scope>IDENTIFICATION IN THE MLL1/MLL COMPLEX</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-197; SER-518; SER-680; THR-840; SER-1056; THR-1845; SER-2098; THR-2147; SER-2151; THR-2525; SER-2955; SER-3036; THR-3372 AND SER-3511</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="24242" last="24256">
<title>On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.</title>
<authorList>
<person name="Patel A."/>
<person name="Dharmarajan V."/>
<person name="Vought V.E."/>
<person name="Cosgrove M.S."/>
</authorList>
<dbReference type="PubMed" id="19556245"/>
<dbReference type="DOI" id="10.1074/jbc.m109.014498"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF THE MLL1/MLL COMPLEX</scope>
<scope>INTERACTION WITH WDR5</scope>
<scope>MUTAGENESIS OF ASN-3906 AND TYR-3942</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1858</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-2098 AND SER-3515</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-636; LYS-1130 AND LYS-1235</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-197; SER-926; SER-2955 AND THR-3372</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2201</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Am. J. Hum. Genet." volume="91" first="358" last="364">
<title>De novo mutations in MLL cause Wiedemann-Steiner syndrome.</title>
<authorList>
<person name="Jones W.D."/>
<person name="Dafou D."/>
<person name="McEntagart M."/>
<person name="Woollard W.J."/>
<person name="Elmslie F.V."/>
<person name="Holder-Espinasse M."/>
<person name="Irving M."/>
<person name="Saggar A.K."/>
<person name="Smithson S."/>
<person name="Trembath R.C."/>
<person name="Deshpande C."/>
<person name="Simpson M.A."/>
</authorList>
<dbReference type="PubMed" id="22795537"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2012.06.008"/>
</citation>
<scope>INVOLVEMENT IN WDSTS</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="Cell" volume="151" first="1097" last="1112">
<title>Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation.</title>
<authorList>
<person name="Yang Y.J."/>
<person name="Baltus A.E."/>
<person name="Mathew R.S."/>
<person name="Murphy E.A."/>
<person name="Evrony G.D."/>
<person name="Gonzalez D.M."/>
<person name="Wang E.P."/>
<person name="Marshall-Walker C.A."/>
<person name="Barry B.J."/>
<person name="Murn J."/>
<person name="Tatarakis A."/>
<person name="Mahajan M.A."/>
<person name="Samuels H.H."/>
<person name="Shi Y."/>
<person name="Golden J.A."/>
<person name="Mahajnah M."/>
<person name="Shenhav R."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="23178126"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.10.043"/>
</citation>
<scope>INTERACTION WITH ZNF335</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1858; SER-2098; THR-2525; SER-2611; SER-2796; SER-2955; SER-3036; SER-3511 AND SER-3527</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1837</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2528</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="4503" last="4512">
<title>Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.</title>
<authorList>
<person name="Allen M.D."/>
<person name="Grummitt C.G."/>
<person name="Hilcenko C."/>
<person name="Min S.Y."/>
<person name="Tonkin L.M."/>
<person name="Johnson C.M."/>
<person name="Freund S.M."/>
<person name="Bycroft M."/>
<person name="Warren A.J."/>
</authorList>
<dbReference type="PubMed" id="16990798"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601340"/>
</citation>
<scope>STRUCTURE BY NMR OF 1146-1214 IN COMPLEX WITH ZINC</scope>
<scope>DOMAIN CXXC-TYPE ZINC-FINGER</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF ARG-1151; ARG-1153; ARG-1154; CYS-1155; CYS-1158; CYS-1161; GLN-1162; ASP-1166; CYS-1167; CYS-1170; ASN-1172; CYS-1173; ASP-1175; LYS-1176; 1178-LYS--GLY-1181; LYS-1178; PHE-1179; ASN-1183; LYS-1185; LYS-1186; GLN-1187; CYS-1188; CYS-1189; ARG-1192; LYS-1193; CYS-1194; GLN-1195 AND ASN-1196</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="J. Mol. Biol." volume="355" first="1005" last="1013">
<title>Structural basis for cooperative transcription factor binding to the CBP coactivator.</title>
<authorList>
<person name="De Guzman R.N."/>
<person name="Goto N.K."/>
<person name="Dyson H.J."/>
<person name="Wright P.E."/>
</authorList>
<dbReference type="PubMed" id="16253272"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.09.059"/>
</citation>
<scope>STRUCTURE BY NMR OF 2842-2869 IN COMPLEX WITH CREBBP</scope>
</reference>
<reference key="51" evidence="2">
<citation type="submission" date="2007-12" db="PDB data bank">
<title>Structural basis for maintenance of unmethylated CpG elements by the CXXC domain of MLL and its critical contributions to MLL-AF9 immortalization activity.</title>
<authorList>
<person name="Cierpicki T."/>
<person name="Riesbeck L.E."/>
<person name="Grembecka J."/>
<person name="Lukasik S.M."/>
<person name="Omonkowska M."/>
<person name="Shultis D."/>
<person name="Zeleznik-Le N.J."/>
<person name="Bushweller J.H."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 1147-1203</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="32158" last="32161">
<title>Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.</title>
<authorList>
<person name="Patel A."/>
<person name="Dharmarajan V."/>
<person name="Cosgrove M.S."/>
</authorList>
<dbReference type="PubMed" id="18829459"/>
<dbReference type="DOI" id="10.1074/jbc.c800164200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.37 ANGSTROMS) OF 3764-3776 IN COMPLEX WITH WDR5</scope>
<scope>INTERACTION WITH WDR5</scope>
</reference>
<reference key="53" evidence="12">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="35258" last="35264">
<title>WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.</title>
<authorList>
<person name="Song J.J."/>
<person name="Kingston R.E."/>
</authorList>
<dbReference type="PubMed" id="18840606"/>
<dbReference type="DOI" id="10.1074/jbc.m806900200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.37 ANGSTROMS) OF 3764-3776 IN COMPLEX WITH WDR5</scope>
<scope>INTERACTION WITH WDR5</scope>
<scope>MUTAGENESIS OF ARG-3765 AND HIS-3769</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="Mol. Cell" volume="33" first="181" last="191">
<title>Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.</title>
<authorList>
<person name="Southall S.M."/>
<person name="Wong P.S."/>
<person name="Odho Z."/>
<person name="Roe S.M."/>
<person name="Wilson J.R."/>
</authorList>
<dbReference type="PubMed" id="19187761"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.12.029"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 3785-3969 IN COMPLEX WITH ZINC; S-ADENOSYL-L-HOMOCYSTEINE AND HISTONE H3 PEPTIDE</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DOMAIN SET</scope>
<scope>INTERACTION WITH ASH2L AND RBBP5</scope>
<scope>MUTAGENESIS OF TYR-3858; GLN-3867; ASP-3869; ARG-3871; GLU-3872; TYR-3874; LYS-3878 AND TYR-3942</scope>
</reference>
<reference key="55" evidence="5">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="6576" last="6586">
<title>The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression.</title>
<authorList>
<person name="Park S."/>
<person name="Osmers U."/>
<person name="Raman G."/>
<person name="Schwantes R.H."/>
<person name="Diaz M.O."/>
<person name="Bushweller J.H."/>
</authorList>
<dbReference type="PubMed" id="20677832"/>
<dbReference type="DOI" id="10.1021/bi1009387"/>
</citation>
<scope>STRUCTURE BY NMR OF 1564-1628 IN COMPLEX WITH ZINC</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF TRP-1594; VAL-1617 AND TYR-1619</scope>
<scope>INTERACTION WITH PPIE</scope>
</reference>
<reference key="56" evidence="4 13 14 15">
<citation type="journal article" date="2010" name="Cell" volume="141" first="1183" last="1194">
<title>Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression.</title>
<authorList>
<person name="Wang Z."/>
<person name="Song J."/>
<person name="Milne T.A."/>
<person name="Wang G.G."/>
<person name="Li H."/>
<person name="Allis C.D."/>
<person name="Patel D.J."/>
</authorList>
<dbReference type="PubMed" id="20541251"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.05.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 1566-1784 IN COMPLEX WITH ZINC AND METHYLATED HISTONE H3</scope>
<scope>INTERACTION WITH PPIE</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF TYR-1581; GLN-1587 AND TRP-1594</scope>
</reference>
<reference key="57" evidence="3">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="62" last="68">
<title>Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.</title>
<authorList>
<person name="Cierpicki T."/>
<person name="Risner L.E."/>
<person name="Grembecka J."/>
<person name="Lukasik S.M."/>
<person name="Popovic R."/>
<person name="Omonkowska M."/>
<person name="Shultis D.D."/>
<person name="Zeleznik-Le N.J."/>
<person name="Bushweller J.H."/>
</authorList>
<dbReference type="PubMed" id="20010842"/>
<dbReference type="DOI" id="10.1038/nsmb.1714"/>
</citation>
<scope>STRUCTURE BY NMR OF 1147-1203 IN COMPLEX WITH ZINC AND TARGET DNA</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN CXXC-TYPE ZINC-FINGER</scope>
<scope>MUTAGENESIS OF ARG-1150; ARG-1154; LYS-1185; GLN-1187; CYS-1188; LYS-1193; LEU-1197 AND MET-1200</scope>
</reference>
<reference key="58" evidence="16">
<citation type="journal article" date="2011" name="Structure" volume="19" first="101" last="108">
<title>Structural and biochemical insights into MLL1 core complex assembly.</title>
<authorList>
<person name="Avdic V."/>
<person name="Zhang P."/>
<person name="Lanouette S."/>
<person name="Groulx A."/>
<person name="Tremblay V."/>
<person name="Brunzelle J."/>
<person name="Couture J.F."/>
</authorList>
<dbReference type="PubMed" id="21220120"/>
<dbReference type="DOI" id="10.1016/j.str.2010.09.022"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 3761-3770 IN COMPLEX WITH RBBP5 AND WDR5</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="59" evidence="20">
<citation type="journal article" date="2012" name="Blood" volume="120" first="4461" last="4469">
<title>Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia.</title>
<authorList>
<person name="Shi A."/>
<person name="Murai M.J."/>
<person name="He S."/>
<person name="Lund G."/>
<person name="Hartley T."/>
<person name="Purohit T."/>
<person name="Reddy G."/>
<person name="Chruszcz M."/>
<person name="Grembecka J."/>
<person name="Cierpicki T."/>
</authorList>
<dbReference type="PubMed" id="22936661"/>
<dbReference type="DOI" id="10.1182/blood-2012-05-429274"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 6-15 IN COMPLEX WITH MEN1</scope>
<scope>INTERACTION WITH MEN1</scope>
<scope>INTERACTION OF FUSION PROTEIN KMT2A-MLLT3 WITH MEN1</scope>
</reference>
<reference key="60" evidence="19">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="27275" last="27289">
<title>Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.</title>
<authorList>
<person name="Dharmarajan V."/>
<person name="Lee J.H."/>
<person name="Patel A."/>
<person name="Skalnik D.G."/>
<person name="Cosgrove M.S."/>
</authorList>
<dbReference type="PubMed" id="22665483"/>
<dbReference type="DOI" id="10.1074/jbc.m112.364125"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 3755-3771 IN COMPLEX WITH WDR5</scope>
<scope>INTERACTION WITH THE WRAD COMPLEX</scope>
<scope>INTERACTION WITH WDR5</scope>
<scope>MUTAGENESIS OF SER-3763; ARG-3765 AND HIS-3769</scope>
<scope>MOTIF WIN</scope>
</reference>
<reference key="61" evidence="17 18">
<citation type="journal article" date="2012" name="Nature" volume="482" first="542" last="546">
<title>The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.</title>
<authorList>
<person name="Huang J."/>
<person name="Gurung B."/>
<person name="Wan B."/>
<person name="Matkar S."/>
<person name="Veniaminova N.A."/>
<person name="Wan K."/>
<person name="Merchant J.L."/>
<person name="Hua X."/>
<person name="Lei M."/>
</authorList>
<dbReference type="PubMed" id="22327296"/>
<dbReference type="DOI" id="10.1038/nature10806"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 6-25 AND 103-153 IN COMPLEX WITH MEN1 AND PSIP1</scope>
<scope>INTERACTION WITH MEN1</scope>
<scope>INTERACTION OF KMT2A-MEN1 COMPLEX WITH PSIP1</scope>
<scope>MOTIF MBM</scope>
<scope>MUTAGENESIS OF ARG-6; TRP-7; ARG-8; PHE-9; PRO-10; ALA-11; ARG-12; PRO-13; ARG-24 AND ARG-25</scope>
</reference>
<reference key="62" evidence="6 7">
<citation type="journal article" date="2013" name="ACS Chem. Biol." volume="8" first="1600" last="1610">
<title>Allosteric communication in the KIX domain proceeds through dynamic repacking of the hydrophobic core.</title>
<authorList>
<person name="Bruschweiler S."/>
<person name="Konrat R."/>
<person name="Tollinger M."/>
</authorList>
<dbReference type="PubMed" id="23651431"/>
<dbReference type="DOI" id="10.1021/cb4002188"/>
</citation>
<scope>STRUCTURE BY NMR OF 2840-2858 IN COMPLEX WITH CREBBP AND CREB1</scope>
</reference>
<reference key="63" evidence="9">
<citation type="journal article" date="2014" name="Blood" volume="124" first="3730" last="3737">
<title>The same site on the integrase-binding domain of lens epithelium-derived growth factor is a therapeutic target for MLL leukemia and HIV.</title>
<authorList>
<person name="Murai M.J."/>
<person name="Pollock J."/>
<person name="He S."/>
<person name="Miao H."/>
<person name="Purohit T."/>
<person name="Yokom A."/>
<person name="Hess J.L."/>
<person name="Muntean A.G."/>
<person name="Grembecka J."/>
<person name="Cierpicki T."/>
</authorList>
<dbReference type="PubMed" id="25305204"/>
<dbReference type="DOI" id="10.1182/blood-2014-01-550079"/>
</citation>
<scope>STRUCTURE BY NMR OF 110-160 IN COMPLEX WITH PSIP1</scope>
<scope>DOMAIN IBM MOTIF</scope>
<scope>INTERACTION WITH PSIP1 AND MEN1</scope>
<scope>INTERACTION OF FUSION PROTEIN KMT2A-MLLT3 WITH PSIP1 AND MEN1</scope>
<scope>MUTAGENESIS OF PHE-129; PHE-148 AND LEU-149</scope>
</reference>
<reference key="64" evidence="8">
<citation type="journal article" date="2014" name="Cancer Res." volume="74" first="5139" last="5151">
<title>Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.</title>
<authorList>
<person name="Cermakova K."/>
<person name="Tesina P."/>
<person name="Demeulemeester J."/>
<person name="El Ashkar S."/>
<person name="Mereau H."/>
<person name="Schwaller J."/>
<person name="Rezacova P."/>
<person name="Veverka V."/>
<person name="De Rijck J."/>
</authorList>
<dbReference type="PubMed" id="25082813"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-13-3602"/>
</citation>
<scope>STRUCTURE BY NMR OF 140-160 IN COMPLEX WITH PSIP1</scope>
<scope>INTERACTION WITH PSIP1</scope>
<scope>MUTAGENESIS OF PHE-129; PHE-133; GLU-144; GLU-146; PHE-148 AND PHE-151</scope>
</reference>
<reference key="65" evidence="22 23">
<citation type="journal article" date="2016" name="Nature" volume="530" first="447" last="452">
<title>Structural basis for activity regulation of MLL family methyltransferases.</title>
<authorList>
<person name="Li Y."/>
<person name="Han J."/>
<person name="Zhang Y."/>
<person name="Cao F."/>
<person name="Liu Z."/>
<person name="Li S."/>
<person name="Wu J."/>
<person name="Hu C."/>
<person name="Wang Y."/>
<person name="Shuai J."/>
<person name="Chen J."/>
<person name="Cao L."/>
<person name="Li D."/>
<person name="Shi P."/>
<person name="Tian C."/>
<person name="Zhang J."/>
<person name="Dou Y."/>
<person name="Li G."/>
<person name="Chen Y."/>
<person name="Lei M."/>
</authorList>
<dbReference type="PubMed" id="26886794"/>
<dbReference type="DOI" id="10.1038/nature16952"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 3813-3969 IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE AND ZINC</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ASN-3861; ARG-3864 AND GLN-3867</scope>
</reference>
<reference key="66" evidence="24">
<citation type="submission" date="2016-08" db="PDB data bank">
<title>Design of a nanomolar affinity ligand to the KIX domain of CBP.</title>
<authorList>
<person name="Langelaan D.N."/>
<person name="Smith S.P."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 2839-2869</scope>
</reference>
<reference key="67" evidence="25">
<citation type="journal article" date="2018" name="Proc. Natl. Acad. Sci. U.S.A." volume="115" first="E7053" last="E7062">
<title>Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.</title>
<authorList>
<person name="Sharma S."/>
<person name="Cermakova K."/>
<person name="De Rijck J."/>
<person name="Demeulemeester J."/>
<person name="Fabry M."/>
<person name="El Ashkar S."/>
<person name="Van Belle S."/>
<person name="Lepsik M."/>
<person name="Tesina P."/>
<person name="Duchoslav V."/>
<person name="Novak P."/>
<person name="Hubalek M."/>
<person name="Srb P."/>
<person name="Christ F."/>
<person name="Rezacova P."/>
<person name="Hodges H.C."/>
<person name="Debyser Z."/>
<person name="Veverka V."/>
</authorList>
<dbReference type="PubMed" id="29997176"/>
<dbReference type="DOI" id="10.1073/pnas.1803909115"/>
</citation>
<scope>STRUCTURE BY NMR OF 111-160 IN COMPLEX WITH PSIP1</scope>
<scope>INTERACTION WITH PSIP1</scope>
<scope>DOMAIN IBM MOTIF</scope>
<scope>MUTAGENESIS OF VAL-132; PHE-133; SER-136 AND SER-142</scope>
<scope>PHOSPHORYLATION AT SER-136; SER-142 AND SER-153</scope>
</reference>
<reference key="68" evidence="21">
<citation type="journal article" date="2018" name="Structure" volume="26" first="85" last="95.e3">
<title>DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants.</title>
<authorList>
<person name="Xu C."/>
<person name="Liu K."/>
<person name="Lei M."/>
<person name="Yang A."/>
<person name="Li Y."/>
<person name="Hughes T.R."/>
<person name="Min J."/>
</authorList>
<dbReference type="PubMed" id="29276034"/>
<dbReference type="DOI" id="10.1016/j.str.2017.11.022"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 1147-1204 IN COMPLEX WITH CPG DNA</scope>
<scope>DOMAIN CXXC-TYPE ZINC-FINGER</scope>
<scope>ZINC-BINDING</scope>
</reference>
<comment type="function">
<text evidence="35 44 45 49 56 57 58 61 70 81">Histone methyltransferase that plays an essential role in early development and hematopoiesis. Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac). In the MLL1/MLL complex, it specifically mediates H3K4me, a specific tag for epigenetic transcriptional activation (PubMed:12453419, PubMed:20677832, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9'. Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20677832, PubMed:20010842). Promotes PPP1R15A-induced apoptosis. Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-ARNTL/BMAL1 heterodimer. Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-ARNTL/BMAL1 to chromatin (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="45 56 70">
<text>L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-methionine = 3 H(+) + N(6),N(6),N(6)-trimethyl-L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-homocysteine</text>
<dbReference type="Rhea" id="RHEA:60260"/>
<dbReference type="Rhea" id="RHEA-COMP:15537"/>
<dbReference type="Rhea" id="RHEA-COMP:15547"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57856"/>
<dbReference type="ChEBI" id="CHEBI:59789"/>
<dbReference type="ChEBI" id="CHEBI:61961"/>
<dbReference type="EC" id="2.1.1.354"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="35 44 46 47 48 49 50 51 53 54 55 56 57 59 60 61 62 63 66 67 68 69 70 72 74">MLL cleavage product N320 heterodimerizes with MLL cleavage product C180 (via SET and FYRC domains). Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, HCFC2, WDR5, DPY30 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MEN1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10 (PubMed:15199122, PubMed:15960975, PubMed:17500065, PubMed:19556245, PubMed:19187761, PubMed:26886794). Interacts (via WIN motif) with WDR5; the interaction is direct (PubMed:19556245, PubMed:18829459, PubMed:22665483, PubMed:18840606). Interaction with WDR5 is required for stable interaction with ASH2L and RBBP5, and thereby also for optimal histone methyltransferase activity (PubMed:26886794). Interacts with KAT8/MOF; the interaction is direct (PubMed:15960975). Interacts with SBF1 and PPP1R15A (PubMed:9537414, PubMed:10490642). Interacts with ZNF335 (PubMed:23178126). Interacts with CLOCK and ARNTL/BMAL1 in a circadian manner (By similarity). Interacts with PPIE; this results in decreased histone H3 methyltransferase activity (PubMed:20677832, PubMed:20541251). Interacts with CREBBP (PubMed:16253272). Interacts with the WRAD complex composed of WDR5, RBBP5, ASH2L and DPY30 (PubMed:22665483). Interacts (via MBM motif) with MEN1 (PubMed:22936661, PubMed:22327296, PubMed:25305204). Interacts (via IBM motifs) with PSIP1 (via IBD domain) with moderate affinity whereas the KMT2A-MEN1 complex interacts with a greater affinity; MEN1 enhances interaction of KMT2A with PSIP1 (PubMed:22327296, PubMed:25305204, PubMed:25082813, PubMed:29997176). Phosphorylation increases its affinity for PSIP1 (PubMed:29997176). Forms a complex with CREBBP and CREB1 (PubMed:23651431).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-16130425">
<id>Q9UBL3-3</id>
<label>ASH2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
<label>CDC73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-1019583">
<id>Q6PD62</id>
<label>CTR9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-79722">
<id>P68431</id>
<label>H3C12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-896414">
<id>Q9H7Z6</id>
<label>KAT8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-591370">
<id>Q03164</id>
<label>KMT2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-9869387">
<id>O00255-2</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-2607770">
<id>Q8N7H5</id>
<label>PAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-591818">
<id>Q9UNP9</id>
<label>PPIE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-592823">
<id>Q15291</id>
<label>RBBP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-15490084">
<id>Q13309-1</id>
<label>SKP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-644534">
<id>Q9WTL8</id>
<label>Arntl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-79859">
<id>O08785</id>
<label>Clock</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-591370">
<id>Q03164</id>
</interactant>
<interactant intactId="EBI-296306">
<id>P45481</id>
<label>Crebbp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2610266">
<id>PRO_0000390949</id>
</interactant>
<interactant intactId="EBI-296331">
<id>Q02548</id>
<label>PAX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2638616">
<id>PRO_0000390950</id>
</interactant>
<interactant intactId="EBI-948013">
<id>Q92794</id>
<label>KAT6A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2638616">
<id>PRO_0000390950</id>
</interactant>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="46">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>MLL cleavage product N320</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>MLL cleavage product C180</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Localizes to a diffuse nuclear pattern when not associated with MLL cleavage product N320.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q03164-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q03164-2</id>
<name>2</name>
<name>14P-18B</name>
<sequence type="described" ref="VSP_006666"/>
</isoform>
<isoform>
<id>Q03164-3</id>
<name>3</name>
<sequence type="described" ref="VSP_046879"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Heart, lung, brain and T- and B-lymphocytes.</text>
</comment>
<comment type="domain">
<text evidence="52">The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.</text>
</comment>
<comment type="domain">
<text evidence="56 70">The SET domain structure is atypical and is not in an optimal position to have methyltransferase activity. It requires other components of the MLL1/MLL complex, such as ASH2L or RBBP5, to order the active site and obtain optimal histone methyltransferase activity.</text>
</comment>
<comment type="domain">
<text evidence="51 58 71">The CXXC-type zinc finger binds to DNA sequence elements containing unnmethylated CpG dinucleotides.</text>
</comment>
<comment type="domain">
<text evidence="59 60">The third PHD-type zinc-finger binds both trimethylated histone H3K4me3 and PPIE; histone and PPIE bind to distinct surfaces (PubMed:20677832, PubMed:20541251). Nevertheless, PPIE binding and histone binding are mutually inhibitory (PubMed:20677832). Isomerization of a peptidylproline bond in the linker between the third PHD-type zinc-finger and the bromo domain disrupts the interaction between the bromo domain and the third PHD-type zinc-finger, and thereby facilitates interaction with PPIE (PubMed:20541251).</text>
</comment>
<comment type="PTM">
<text evidence="46 47">Proteolytic cleavage by TASP1 generates MLL cleavage product N320 and MLL cleavage product C180, which reassemble through a non-covalent association. 2 cleavage sites exist, cleavage site 1 (CS1) and cleavage site 2 (CS2), to generate MLL cleavage products N320 and C180. CS2 is the major site.</text>
</comment>
<comment type="PTM">
<text evidence="72">Phosphorylation increases its interaction with PSIP1.</text>
</comment>
<comment type="disease" evidence="64">
<disease id="DI-03533">
<name>Wiedemann-Steiner syndrome</name>
<acronym>WDSTS</acronym>
<description>A syndrome characterized by hairy elbows (hypertrichosis cubiti), intellectual disability, a distinctive facial appearance, and short stature. Facial characteristics include long eyelashes, thick or arched eyebrows with a lateral flare, and downslanting and vertically narrow palpebral fissures.</description>
<dbReference type="MIM" id="605130"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="44 65 69">Chromosomal aberrations involving KMT2A are a cause of acute leukemias. Translocation t(1;11)(q21;q23) with MLLT11/AF1Q; translocation t(3;11)(p21;q23) with NCKIPSD/AF3p21; translocation t(3,11)(q25,q23) with GMPS; translocation t(4;11)(q21;q23) with AFF1/MLLT2/AF4; insertion ins(5;11)(q31;q13q23) with AFF4/AF5Q31; translocation t(5;11)(q12;q23) with AF5-alpha/CENPK; translocation t(6;11)(q27;q23) with AFDN; translocation t(9;11)(p22;q23) with MLLT3/AF9; translocation t(10;11)(p11.2;q23) with ABI1; translocation t(10;11)(p12;q23) with MLLT10/AF10; t(11;15)(q23;q14) with KNL1 and ZFYVE19; translocation t(11;17)(q23;q21) with MLLT6/AF17; translocation t(11;19)(q23;p13.3) with ELL; translocation t(11;19)(q23;p13.3) with MLLT1/ENL; translocation t(11;19)(q23;p23) with GAS7; translocation t(X;11)(q13;q23) with FOXO4/AFX1. Translocation t(3;11)(q28;q23) with LPP. Translocation t(10;11)(q22;q23) with TET1. Translocation t(9;11)(q34;q23) with DAB2IP. Translocation t(4;11)(p12;q23) with FRYL. Fusion proteins KMT2A-MLLT1, KMT2A-MLLT3 and KMT2A-ELL interact with PPP1R15A and, on the contrary to unfused KMT2A, inhibit PPP1R15A-induced apoptosis. Fusion protein KMT2A-MLLT3 interacts with MEN1 and PSIP1 (PubMed:22936661, PubMed:25305204).</text>
</comment>
<comment type="disease">
<text evidence="44">A chromosomal aberration involving KMT2A may be a cause of chronic neutrophilic leukemia. Translocation t(4;11)(q21;q23) with SEPT11.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the class V-like SAM-binding methyltransferase superfamily. Histone-lysine methyltransferase family. TRX/MLL subfamily.</text>
</comment>
<comment type="sequence caution" evidence="80">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAA58669" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="80">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAG26332" version="2"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="80">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="BAD92745" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MLLID13.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/mll/"/>
</comment>
<dbReference type="EC" id="2.1.1.354" evidence="45 56 70"/>
<dbReference type="EMBL" id="L04284">
<property type="protein sequence ID" value="AAA58669.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69744">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69745">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69746">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69747">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69748">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69749">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69750">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69751">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69752">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69753">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69754">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69755">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69756">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69757">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69758">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69759">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69760">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69761">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69762">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69763">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69764">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69765">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69766">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69767">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69768">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69769">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69770">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69772">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69773">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69774">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69775">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69776">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69777">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69778">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69779">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z69780">
<property type="protein sequence ID" value="CAA93625.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY373585">
<property type="protein sequence ID" value="AAQ63624.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000941">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001267">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D14540">
<property type="protein sequence ID" value="BAA03407.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209508">
<property type="protein sequence ID" value="BAD92745.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L04731">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L01986">
<property type="protein sequence ID" value="AAA92511.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83604">
<property type="protein sequence ID" value="CAA58584.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S78570">
<property type="protein sequence ID" value="AAB34770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U04737">
<property type="protein sequence ID" value="AAA18644.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S66432">
<property type="protein sequence ID" value="AAB28545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF232001">
<property type="protein sequence ID" value="AAG26335.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF231998">
<property type="protein sequence ID" value="AAG26332.2"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31686.1">
<molecule id="Q03164-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55791.1">
<molecule id="Q03164-3"/>
</dbReference>
<dbReference type="PIR" id="A44265">
<property type="entry name" value="A44265"/>
</dbReference>
<dbReference type="PIR" id="I52578">
<property type="entry name" value="I52578"/>
</dbReference>
<dbReference type="PIR" id="I53035">
<property type="entry name" value="I53035"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001184033.1">
<molecule id="Q03164-3"/>
<property type="nucleotide sequence ID" value="NM_001197104.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005924.2">
<molecule id="Q03164-1"/>
<property type="nucleotide sequence ID" value="NM_005933.3"/>
</dbReference>
<dbReference type="PDB" id="2AGH">
<property type="method" value="NMR"/>
<property type="chains" value="C=2840-2869"/>
</dbReference>
<dbReference type="PDB" id="2J2S">
<property type="method" value="NMR"/>
<property type="chains" value="A=1143-1214"/>
</dbReference>
<dbReference type="PDB" id="2JYI">
<property type="method" value="NMR"/>
<property type="chains" value="A=1147-1203"/>
</dbReference>
<dbReference type="PDB" id="2KKF">
<property type="method" value="NMR"/>
<property type="chains" value="A=1147-1203"/>
</dbReference>
<dbReference type="PDB" id="2KU7">
<property type="method" value="NMR"/>
<property type="chains" value="A=1585-1628"/>
</dbReference>
<dbReference type="PDB" id="2KYU">
<property type="method" value="NMR"/>
<property type="chains" value="A=1564-1628"/>
</dbReference>
<dbReference type="PDB" id="2LXS">
<property type="method" value="NMR"/>
<property type="chains" value="B=2840-2858"/>
</dbReference>
<dbReference type="PDB" id="2LXT">
<property type="method" value="NMR"/>
<property type="chains" value="B=2840-2858"/>
</dbReference>
<dbReference type="PDB" id="2MSR">
<property type="method" value="NMR"/>
<property type="chains" value="A=140-160"/>
</dbReference>
<dbReference type="PDB" id="2MTN">
<property type="method" value="NMR"/>
<property type="chains" value="A=110-160"/>
</dbReference>
<dbReference type="PDB" id="2W5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=3785-3969"/>
</dbReference>
<dbReference type="PDB" id="2W5Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=3785-3969"/>
</dbReference>
<dbReference type="PDB" id="3EG6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="C=3762-3773"/>
</dbReference>
<dbReference type="PDB" id="3EMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.37"/>
<property type="chains" value="B=3764-3776"/>
</dbReference>
<dbReference type="PDB" id="3LQH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="A=1566-1784"/>
</dbReference>
<dbReference type="PDB" id="3LQI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A/B/C=1566-1784"/>
</dbReference>
<dbReference type="PDB" id="3LQJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1566-1784"/>
</dbReference>
<dbReference type="PDB" id="3P4F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="C=3761-3770"/>
</dbReference>
<dbReference type="PDB" id="3U85">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B=6-25"/>
</dbReference>
<dbReference type="PDB" id="3U88">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="M/N=103-153"/>
</dbReference>
<dbReference type="PDB" id="4ESG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C/D=3755-3771"/>
</dbReference>
<dbReference type="PDB" id="4GQ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="B=6-15"/>
</dbReference>
<dbReference type="PDB" id="4NW3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A=1147-1204"/>
</dbReference>
<dbReference type="PDB" id="5F5E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=3813-3969"/>
</dbReference>
<dbReference type="PDB" id="5F6L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=3813-3969"/>
</dbReference>
<dbReference type="PDB" id="5SVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="B=2839-2869"/>
</dbReference>
<dbReference type="PDB" id="6EMQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=111-160"/>
</dbReference>
<dbReference type="PDB" id="6KIU">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="K=3754-3969"/>
</dbReference>
<dbReference type="PDB" id="6KIV">
<property type="method" value="EM"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="K=3754-3969"/>
</dbReference>
<dbReference type="PDB" id="6KIX">
<property type="method" value="EM"/>
<property type="resolution" value="4.10"/>
<property type="chains" value="K=3754-3969"/>
</dbReference>
<dbReference type="PDB" id="6KIZ">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="K=3754-3969"/>
</dbReference>
<dbReference type="PDB" id="6PWV">
<property type="method" value="EM"/>
<property type="resolution" value="6.20"/>
<property type="chains" value="C=3762-3969"/>
</dbReference>
<dbReference type="PDB" id="6PWW">
<property type="method" value="EM"/>
<property type="resolution" value="4.40"/>
<property type="chains" value="C=3762-3969"/>
</dbReference>
<dbReference type="PDBsum" id="2AGH"/>
<dbReference type="PDBsum" id="2J2S"/>
<dbReference type="PDBsum" id="2JYI"/>
<dbReference type="PDBsum" id="2KKF"/>
<dbReference type="PDBsum" id="2KU7"/>
<dbReference type="PDBsum" id="2KYU"/>
<dbReference type="PDBsum" id="2LXS"/>
<dbReference type="PDBsum" id="2LXT"/>
<dbReference type="PDBsum" id="2MSR"/>
<dbReference type="PDBsum" id="2MTN"/>
<dbReference type="PDBsum" id="2W5Y"/>
<dbReference type="PDBsum" id="2W5Z"/>
<dbReference type="PDBsum" id="3EG6"/>
<dbReference type="PDBsum" id="3EMH"/>
<dbReference type="PDBsum" id="3LQH"/>
<dbReference type="PDBsum" id="3LQI"/>
<dbReference type="PDBsum" id="3LQJ"/>
<dbReference type="PDBsum" id="3P4F"/>
<dbReference type="PDBsum" id="3U85"/>
<dbReference type="PDBsum" id="3U88"/>
<dbReference type="PDBsum" id="4ESG"/>
<dbReference type="PDBsum" id="4GQ6"/>
<dbReference type="PDBsum" id="4NW3"/>
<dbReference type="PDBsum" id="5F5E"/>
<dbReference type="PDBsum" id="5F6L"/>
<dbReference type="PDBsum" id="5SVH"/>
<dbReference type="PDBsum" id="6EMQ"/>
<dbReference type="PDBsum" id="6KIU"/>
<dbReference type="PDBsum" id="6KIV"/>
<dbReference type="PDBsum" id="6KIX"/>
<dbReference type="PDBsum" id="6KIZ"/>
<dbReference type="PDBsum" id="6PWV"/>
<dbReference type="PDBsum" id="6PWW"/>
<dbReference type="BMRB" id="Q03164"/>
<dbReference type="SASBDB" id="Q03164"/>
<dbReference type="SMR" id="Q03164"/>
<dbReference type="BioGRID" id="110443">
<property type="interactions" value="134"/>
</dbReference>
<dbReference type="CORUM" id="Q03164"/>
<dbReference type="DIP" id="DIP-29221N"/>
<dbReference type="ELM" id="Q03164"/>
<dbReference type="IntAct" id="Q03164">
<property type="interactions" value="62"/>
</dbReference>
<dbReference type="MINT" id="Q03164"/>
<dbReference type="STRING" id="9606.ENSP00000436786"/>
<dbReference type="BindingDB" id="Q03164"/>
<dbReference type="ChEMBL" id="CHEMBL1293299"/>
<dbReference type="CarbonylDB" id="Q03164"/>
<dbReference type="GlyConnect" id="2046">
<property type="glycosylation" value="1 N-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q03164">
<property type="glycosylation" value="4 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (3 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q03164"/>
<dbReference type="PhosphoSitePlus" id="Q03164"/>
<dbReference type="BioMuta" id="KMT2A"/>
<dbReference type="DMDM" id="146345435"/>
<dbReference type="EPD" id="Q03164"/>
<dbReference type="jPOST" id="Q03164"/>
<dbReference type="MassIVE" id="Q03164"/>
<dbReference type="MaxQB" id="Q03164"/>
<dbReference type="PaxDb" id="Q03164"/>
<dbReference type="PeptideAtlas" id="Q03164"/>
<dbReference type="PRIDE" id="Q03164"/>
<dbReference type="ProteomicsDB" id="23014"/>
<dbReference type="ProteomicsDB" id="58195">
<molecule id="Q03164-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58196">
<molecule id="Q03164-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="18629">
<property type="antibodies" value="452 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000389506">
<molecule id="Q03164-1"/>
<property type="protein sequence ID" value="ENSP00000374157"/>
<property type="gene ID" value="ENSG00000118058"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000534358">
<molecule id="Q03164-3"/>
<property type="protein sequence ID" value="ENSP00000436786"/>
<property type="gene ID" value="ENSG00000118058"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000649699">
<molecule id="Q03164-2"/>
<property type="protein sequence ID" value="ENSP00000496927"/>
<property type="gene ID" value="ENSG00000118058"/>
</dbReference>
<dbReference type="GeneID" id="4297"/>
<dbReference type="KEGG" id="hsa:4297"/>
<dbReference type="UCSC" id="uc001pta.4">
<molecule id="Q03164-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4297"/>
<dbReference type="DisGeNET" id="4297"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000118058.20"/>
<dbReference type="GeneCards" id="KMT2A"/>
<dbReference type="HGNC" id="HGNC:7132">
<property type="gene designation" value="KMT2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000118058">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="KMT2A"/>
<dbReference type="MIM" id="159555">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="605130">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q03164"/>
<dbReference type="OpenTargets" id="ENSG00000118058"/>
<dbReference type="Orphanet" id="98831">
<property type="disease" value="Acute myeloid leukemia with 11q23 abnormalities"/>
</dbReference>
<dbReference type="Orphanet" id="402017">
<property type="disease" value="Acute myeloid leukemia with t(9;11)(p22;q23)"/>
</dbReference>
<dbReference type="Orphanet" id="98835">
<property type="disease" value="Acute undifferentiated leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="199">
<property type="disease" value="Cornelia de Lange syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="530995">
<property type="disease" value="Mixed phenotype acute leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="319182">
<property type="disease" value="Wiedemann-Steiner syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA241"/>
<dbReference type="eggNOG" id="KOG1084">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160099"/>
<dbReference type="HOGENOM" id="CLU_000208_2_0_1"/>
<dbReference type="InParanoid" id="Q03164"/>
<dbReference type="KO" id="K09186"/>
<dbReference type="OMA" id="YDSKMME"/>
<dbReference type="OrthoDB" id="738155at2759"/>
<dbReference type="PhylomeDB" id="Q03164"/>
<dbReference type="TreeFam" id="TF319820"/>
<dbReference type="BioCyc" id="MetaCyc:HS04188-MONOMER"/>
<dbReference type="PathwayCommons" id="Q03164"/>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8936459">
<property type="pathway name" value="RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="SIGNOR" id="Q03164"/>
<dbReference type="BioGRID-ORCS" id="4297">
<property type="hits" value="97 hits in 864 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KMT2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q03164"/>
<dbReference type="GeneWiki" id="MLL_(gene)"/>
<dbReference type="GenomeRNAi" id="4297"/>
<dbReference type="Pharos" id="Q03164">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q03164"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q03164">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000118058">
<property type="expression patterns" value="Expressed in forebrain and 255 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q03164">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q03164">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0035097">
<property type="term" value="C:histone methyltransferase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071339">
<property type="term" value="C:MLL1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003680">
<property type="term" value="F:AT DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000255"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0042800">
<property type="term" value="F:histone methyltransferase activity (H3-K4 specific)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0070577">
<property type="term" value="F:lysine-acetylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045322">
<property type="term" value="F:unmethylated CpG binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035162">
<property type="term" value="P:embryonic hemopoiesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044648">
<property type="term" value="P:histone H3-K4 dimethylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0051568">
<property type="term" value="P:histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097692">
<property type="term" value="P:histone H3-K4 monomethylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0080182">
<property type="term" value="P:histone H3-K4 trimethylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043984">
<property type="term" value="P:histone H4-K16 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905642">
<property type="term" value="P:negative regulation of DNA methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001040">
<property type="term" value="P:positive regulation of cellular response to drug"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032411">
<property type="term" value="P:positive regulation of transporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0065003">
<property type="term" value="P:protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071440">
<property type="term" value="P:regulation of histone H3-K14 acetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000615">
<property type="term" value="P:regulation of histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045652">
<property type="term" value="P:regulation of megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd15693">
<property type="entry name" value="ePHD_KMT2A"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd15588">
<property type="entry name" value="PHD1_KMT2A"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd15590">
<property type="entry name" value="PHD2_KMT2A"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01116"/>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="IDEAL" id="IID00379"/>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034732">
<property type="entry name" value="EPHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR003889">
<property type="entry name" value="FYrich_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR003888">
<property type="entry name" value="FYrich_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR037927">
<property type="entry name" value="KMT2A"/>
</dbReference>
<dbReference type="InterPro" id="IPR041958">
<property type="entry name" value="KMT2A_ePHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR042023">
<property type="entry name" value="KMT2A_PHD1"/>
</dbReference>
<dbReference type="InterPro" id="IPR042025">
<property type="entry name" value="KMT2A_PHD2"/>
</dbReference>
<dbReference type="InterPro" id="IPR016569">
<property type="entry name" value="MeTrfase_trithorax"/>
</dbReference>
<dbReference type="InterPro" id="IPR003616">
<property type="entry name" value="Post-SET_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001214">
<property type="entry name" value="SET_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002857">
<property type="entry name" value="Znf_CXXC"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45838:SF2">
<property type="entry name" value="PTHR45838:SF2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05965">
<property type="entry name" value="FYRC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05964">
<property type="entry name" value="FYRN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00856">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02008">
<property type="entry name" value="zf-CXXC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF010354">
<property type="entry name" value="Methyltransferase_trithorax"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00542">
<property type="entry name" value="FYRC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00541">
<property type="entry name" value="FYRN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00508">
<property type="entry name" value="PostSET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00317">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51805">
<property type="entry name" value="EPHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51543">
<property type="entry name" value="FYRC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51542">
<property type="entry name" value="FYRN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50868">
<property type="entry name" value="POST_SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50280">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51058">
<property type="entry name" value="ZF_CXXC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0489">Methyltransferase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0949">S-adenosyl-L-methionine</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Histone-lysine N-methyltransferase 2A" id="PRO_0000124876">
<location>
<begin position="1"/>
<end position="3969"/>
</location>
</feature>
<feature type="chain" description="MLL cleavage product N320" id="PRO_0000390949">
<location>
<begin position="1"/>
<end position="2718"/>
</location>
</feature>
<feature type="chain" description="MLL cleavage product C180" id="PRO_0000390950">
<location>
<begin position="2719"/>
<end position="3969"/>
</location>
</feature>
<feature type="domain" description="Bromo; divergent" evidence="36">
<location>
<begin position="1703"/>
<end position="1748"/>
</location>
</feature>
<feature type="domain" description="FYR N-terminal" evidence="41">
<location>
<begin position="2018"/>
<end position="2074"/>
</location>
</feature>
<feature type="domain" description="FYR C-terminal" evidence="42">
<location>
<begin position="3666"/>
<end position="3747"/>
</location>
</feature>
<feature type="domain" description="SET" evidence="39">
<location>
<begin position="3829"/>
<end position="3945"/>
</location>
</feature>
<feature type="domain" description="Post-SET" evidence="38">
<location>
<begin position="3953"/>
<end position="3969"/>
</location>
</feature>
<feature type="DNA-binding region" description="A.T hook 1">
<location>
<begin position="169"/>
<end position="180"/>
</location>
</feature>
<feature type="DNA-binding region" description="A.T hook 2">
<location>
<begin position="217"/>
<end position="227"/>
</location>
</feature>
<feature type="DNA-binding region" description="A.T hook 3">
<location>
<begin position="301"/>
<end position="309"/>
</location>
</feature>
<feature type="zinc finger region" description="CXXC-type" evidence="40 71">
<location>
<begin position="1147"/>
<end position="1195"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 1" evidence="37">
<location>
<begin position="1431"/>
<end position="1482"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 2" evidence="37">
<location>
<begin position="1479"/>
<end position="1533"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 3" evidence="37">
<location>
<begin position="1566"/>
<end position="1627"/>
</location>
</feature>
<feature type="zinc finger region" description="C2HC pre-PHD-type" evidence="43">
<location>
<begin position="1870"/>
<end position="1910"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 4" evidence="43">
<location>
<begin position="1931"/>
<end position="1978"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with histone H3K4me3" evidence="60">
<location>
<begin position="1584"/>
<end position="1600"/>
</location>
</feature>
<feature type="region of interest" description="S-adenosyl-L-methionine binding" evidence="10 22 23 56 70">
<location>
<begin position="3906"/>
<end position="3907"/>
</location>
</feature>
<feature type="short sequence motif" description="Menin-binding motif (MBM)" evidence="62">
<location>
<begin position="6"/>
<end position="25"/>
</location>
</feature>
<feature type="short sequence motif" description="Integrase domain-binding motif 1 (IBM1)" evidence="69">
<location>
<begin position="123"/>
<end position="134"/>
</location>
</feature>
<feature type="short sequence motif" description="Integrase domain-binding motif 2 (IBM2)" evidence="69">
<location>
<begin position="147"/>
<end position="152"/>
</location>
</feature>
<feature type="short sequence motif" description="9aaTAD" evidence="52">
<location>
<begin position="2847"/>
<end position="2855"/>
</location>
</feature>
<feature type="short sequence motif" description="WDR5 interaction motif (WIN)" evidence="54 63">
<location>
<begin position="3762"/>
<end position="3767"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala/Gly/Ser-rich">
<location>
<begin position="17"/>
<end position="102"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="137"/>
<end position="143"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="561"/>
<end position="564"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="568"/>
<end position="571"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1155"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1158"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1161"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1167"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1170"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1173"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1189"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="21 71">
<location>
<position position="1194"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="10 11 22 23 51 56">
<location>
<position position="3909"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="10 11 22 23 51 56">
<location>
<position position="3957"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="10 11 22 23 51 56">
<location>
<position position="3959"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="10 11 23 51 56">
<location>
<position position="3964"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine" evidence="10 22 23 39 56 70">
<location>
<position position="3839"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine" evidence="10 22 23 39 56 70">
<location>
<position position="3841"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine" evidence="11 22 39 56 70">
<location>
<position position="3883"/>
</location>
</feature>
<feature type="binding site" description="S-adenosyl-L-methionine" evidence="10 22 23 39 56 70">
<location>
<position position="3958"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-ZFYVE19 oncogene">
<location>
<begin position="1334"/>
<end position="1335"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-AF3P21 and KMT2A-KNL1 oncogenes">
<location>
<begin position="1362"/>
<end position="1363"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-CENPK oncogene">
<location>
<begin position="1362"/>
<end position="1363"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-FRYL fusion protein">
<location>
<position position="1362"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-AFF4 fusion protein">
<location>
<begin position="1406"/>
<end position="1407"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-GAS7 oncogene">
<location>
<begin position="1444"/>
<end position="1445"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A-LPP">
<location>
<begin position="1444"/>
<end position="1445"/>
</location>
</feature>
<feature type="site" description="Cleavage; by TASP1, site 1" evidence="47">
<location>
<begin position="2666"/>
<end position="2667"/>
</location>
</feature>
<feature type="site" description="Cleavage; by TASP1, site 2" evidence="47">
<location>
<begin position="2718"/>
<end position="2719"/>
</location>
</feature>
<feature type="site" description="Important for WDR5-recognition and binding" evidence="57">
<location>
<position position="3765"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="72">
<location>
<position position="136"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="72">
<location>
<position position="142"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 29 30 72">
<location>
<position position="153"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 30">
<location>
<position position="197"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="35">
<location>
<position position="239"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="35">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="28">
<location>
<position position="636"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="680"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26">
<location>
<position position="840"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30">
<location>
<position position="926"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="1056"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="28">
<location>
<position position="1130"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="28">
<location>
<position position="1235"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33">
<location>
<position position="1837"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26">
<location>
<position position="1845"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="27 32">
<location>
<position position="1858"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 29 32">
<location>
<position position="2098"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26">
<location>
<position position="2147"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="2151"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="2201"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26 32">
<location>
<position position="2525"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="2611"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="2796"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 30 32">
<location>
<position position="2955"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="35">
<location>
<position position="2958"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 32">
<location>
<position position="3036"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26 30">
<location>
<position position="3372"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="35">
<location>
<position position="3462"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26 32">
<location>
<position position="3511"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="3515"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="3527"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="34">
<location>
<position position="2528"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006666" evidence="79">
<location>
<begin position="1407"/>
<end position="1444"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046879" evidence="76 78">
<original>S</original>
<variation>SGTE</variation>
<location>
<position position="1603"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332745." id="VAR_021317" evidence="73">
<original>A</original>
<variation>G</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332747." id="VAR_021318" evidence="75">
<original>A</original>
<variation>V</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332772." id="VAR_021319" evidence="75">
<original>E</original>
<variation>K</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs693598." id="VAR_052652">
<original>Q</original>
<variation>P</variation>
<location>
<position position="1975"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332837." id="VAR_021320" evidence="75">
<original>S</original>
<variation>T</variation>
<location>
<position position="2319"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332838." id="VAR_021321" evidence="75">
<original>P</original>
<variation>R</variation>
<location>
<position position="2354"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332839." id="VAR_021322" evidence="75">
<original>Q</original>
<variation>R</variation>
<location>
<position position="2387"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332859." id="VAR_021323" evidence="75">
<original>V</original>
<variation>I</variation>
<location>
<position position="3714"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332861." id="VAR_021324" evidence="75">
<original>S</original>
<variation>A</variation>
<location>
<position position="3773"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>R</original>
<variation>A</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>W</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>R</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with MEN1." evidence="62">
<original>F</original>
<variation>A</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>F</original>
<variation>H</variation>
<variation>Y</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>P</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>A</original>
<variation>R</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>R</original>
<variation>A</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1." evidence="62">
<original>P</original>
<variation>A</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1; when associated with E-25." evidence="62">
<original>R</original>
<variation>E</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with MEN1; when associated with E-24." evidence="62">
<original>R</original>
<variation>E</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="Weakly affects interaction with PSIP1 whereas significantly decreases interaction of KMT2A-MEN1 complex with PSIP1. Reduced interaction with PSIP1; when associated with A-133." evidence="68 69">
<original>F</original>
<variation>A</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with PSIP1; when associated with A-133." evidence="72">
<original>V</original>
<variation>A</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with PSIP1; when associated with A-129 or A-132." evidence="68 72">
<original>F</original>
<variation>A</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant. Significant increase in interaction with PSIP1; when associated with D-142." evidence="72">
<original>S</original>
<variation>D</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant. Significant increase in interaction with PSIP1; when associated with D-136." evidence="72">
<original>S</original>
<variation>D</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PSIP1; when associated with Q-146 and A-148." evidence="68">
<original>E</original>
<variation>Q</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PSIP1; when associated with Q-144 and A-148." evidence="68">
<original>E</original>
<variation>Q</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with PSIP1. Loss of interaction with PSIP1; when associated with A-149 or Q-144 and Q-146." evidence="68 69">
<original>F</original>
<variation>A</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PSIP1; when associated with A-148." evidence="69">
<original>L</original>
<variation>A</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with PSIP1." evidence="68">
<original>F</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="58">
<original>R</original>
<variation>A</variation>
<location>
<position position="1150"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>R</original>
<variation>A</variation>
<location>
<position position="1151"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51">
<original>R</original>
<variation>A</variation>
<location>
<position position="1153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51 58">
<original>R</original>
<variation>A</variation>
<location>
<position position="1154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1158"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1161"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51">
<original>Q</original>
<variation>A</variation>
<location>
<position position="1162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>D</original>
<variation>A</variation>
<location>
<position position="1166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51">
<original>N</original>
<variation>A</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>D</original>
<variation>A</variation>
<location>
<position position="1175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>K</original>
<variation>A</variation>
<location>
<position position="1176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>KFGG</original>
<variation>AAAA</variation>
<location>
<begin position="1178"/>
<end position="1181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>K</original>
<variation>A</variation>
<location>
<position position="1178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>F</original>
<variation>A</variation>
<location>
<position position="1179"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>N</original>
<variation>A</variation>
<location>
<position position="1183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51 58">
<original>K</original>
<variation>A</variation>
<location>
<position position="1185"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51">
<original>K</original>
<variation>A</variation>
<location>
<position position="1186"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51 58">
<original>Q</original>
<variation>A</variation>
<location>
<position position="1187"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51 58">
<original>C</original>
<variation>A</variation>
<location>
<position position="1188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes DNA-binding and increases CpG methylation of the HOXA9 promoter region. Does not lead to the development of leukemia when overexpressed in mice as gene fusion with MLLT3." evidence="58">
<original>C</original>
<variation>D</variation>
<location>
<position position="1188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>R</original>
<variation>A</variation>
<location>
<position position="1192"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA-binding." evidence="51 58">
<original>K</original>
<variation>A</variation>
<location>
<position position="1193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs zinc-binding and stability of the CXXC-type zinc finger and causes loss of DNA-binding." evidence="51">
<original>C</original>
<variation>A</variation>
<location>
<position position="1194"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51">
<original>Q</original>
<variation>A</variation>
<location>
<position position="1195"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability or DNA-binding." evidence="51">
<original>N</original>
<variation>A</variation>
<location>
<position position="1196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly decreases DNA-binding." evidence="58">
<original>L</original>
<variation>A</variation>
<location>
<position position="1197"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on DNA-binding." evidence="58">
<original>M</original>
<variation>A</variation>
<location>
<position position="1200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for histone H3K4me3." evidence="59">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1581"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for histone H3K4me3." evidence="59">
<original>Q</original>
<variation>A</variation>
<location>
<position position="1587"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with histone H3K4me3." evidence="60">
<original>W</original>
<variation>A</variation>
<location>
<position position="1594"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for histone H3K4me3." evidence="59">
<original>W</original>
<variation>E</variation>
<location>
<position position="1594"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases binding affinity for PPIE." evidence="60">
<original>V</original>
<variation>A</variation>
<location>
<position position="1617"/>
</location>
</feature>
<feature type="mutagenesis site" description="May perturb protein folding and thereby decrease binding affinity for PPIE." evidence="60">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1619"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces cleavage without abolishing it. Abolishes cleavage by TASP1; when associated with 2718-A--A-2720." evidence="47">
<original>DG</original>
<variation>AA</variation>
<location>
<begin position="2666"/>
<end position="2667"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage by TASP1; when associated with 2666-A-A-2667." evidence="46 47">
<original>DGV</original>
<variation>AAA</variation>
<location>
<begin position="2718"/>
<end position="2720"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased interaction with WDR5." evidence="63">
<original>S</original>
<variation>A</variation>
<location>
<position position="3763"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with the WRAD complex and WDR5." evidence="55 63">
<original>R</original>
<variation>A</variation>
<location>
<position position="3765"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight decrease in interaction with WDR5." evidence="55">
<original>H</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="3769"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased interaction with WDR5." evidence="63">
<original>H</original>
<variation>Y</variation>
<location>
<position position="3769"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs methyltransferase activity toward unmodified or monomethylated H3K4me." evidence="56">
<original>Y</original>
<variation>A</variation>
<location>
<position position="3858"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly affects methyltransferase activity toward unmodified or monomethylated H3K4me." evidence="56">
<original>Y</original>
<variation>F</variation>
<location>
<position position="3858"/>
</location>
</feature>
<feature type="mutagenesis site" description="Leads to stable interaction with ASH2L and RBBP5 in the absence of WDR5; when associated with L-3867." evidence="70">
<original>N</original>
<variation>I</variation>
<location>
<position position="3861"/>
</location>
</feature>
<feature type="mutagenesis site" description="Leads to stable interaction with ASH2L and RBBP5 in the absence of WDR5; when associated with V-3867." evidence="70">
<original>N</original>
<variation>T</variation>
<location>
<position position="3861"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with ASH2L and RBBP5 and nearly abolishes histone methyltransferase activity." evidence="70">
<original>R</original>
<variation>A</variation>
<location>
<position position="3864"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly affects methyltransferase activity of the enzyme alone, while it impairs methyltransferase activity in complex; when associated with A-3871." evidence="56">
<original>Q</original>
<variation>A</variation>
<location>
<position position="3867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Leads to stable interaction with ASH2L and RBBP5 in the absence of WDR5; when associated with I-3861." evidence="70">
<original>Q</original>
<variation>L</variation>
<location>
<position position="3867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Leads to stable interaction with ASH2L and RBBP5 in the absence of WDR5; when associated with T-3861." evidence="70">
<original>Q</original>
<variation>V</variation>
<location>
<position position="3867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methyltransferase activity of the enzyme alone or in complex; when associated with A-3872." evidence="56">
<original>D</original>
<variation>A</variation>
<location>
<position position="3869"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly affects methyltransferase activity of the enzyme alone, while it impairs methyltransferase activity in complex; when associated with A-3867." evidence="56">
<original>R</original>
<variation>A</variation>
<location>
<position position="3871"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methyltransferase activity of the enzyme alone or in complex; when associated with A-3869." evidence="56">
<original>E</original>
<variation>A</variation>
<location>
<position position="3872"/>
</location>
</feature>
<feature type="mutagenesis site" description="Affects methyltransferase activity of the enzyme alone, while it does not affect methyltransferase activity in complex; when associated with A-3878." evidence="56">
<original>Y</original>
<variation>A</variation>
<location>
<position position="3874"/>
</location>
</feature>
<feature type="mutagenesis site" description="Affects methyltransferase activity of the enzyme alone, while it does not affect methyltransferase activity in complex; when associated with A-3874." evidence="56">
<original>K</original>
<variation>A</variation>
<location>
<position position="3878"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of the histone H3 methyltransferase activity." evidence="57">
<original>N</original>
<variation>A</variation>
<location>
<position position="3906"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs methyltransferase activity toward unmodified or monomethylated H3K4me." evidence="56 57">
<original>Y</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="3942"/>
</location>
</feature>
<feature type="mutagenesis site" description="Shifts from a specific monomethyltransferase to a di- and trimethyltransferase activity." evidence="56 57">
<original>Y</original>
<variation>F</variation>
<location>
<position position="3942"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA93625." ref="2" evidence="80">
<original>E</original>
<variation>ELTTQIPCSWRTKGHIHDKKTEPFRLLAWSWCLN</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA93625 and 6; L04731." ref="2 6" evidence="80">
<original>Q</original>
<variation>E</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAG26335." ref="13" evidence="80">
<original>V</original>
<variation>A</variation>
<location>
<position position="1347"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AAA18644." ref="12" evidence="80">
<original>R</original>
<variation>G</variation>
<location>
<position position="1487"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAG26335." ref="13" evidence="80">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1490"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAG26335." ref="13" evidence="80">
<original>P</original>
<variation>L</variation>
<location>
<position position="1507"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAG26335." ref="13" evidence="80">
<original>N</original>
<variation>T</variation>
<location>
<position position="1513"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAG26335." ref="13" evidence="80">
<original>E</original>
<variation>G</variation>
<location>
<position position="1600"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AAB34770." ref="11" evidence="80">
<original>S</original>
<variation>C</variation>
<location>
<position position="1616"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA92511." ref="8" evidence="80">
<original>Q</original>
<variation>H</variation>
<location>
<position position="1937"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA92511." ref="8" evidence="80">
<original>P</original>
<variation>S</variation>
<location>
<position position="2181"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; L04731." ref="6" evidence="80">
<original>K</original>
<variation>N</variation>
<location>
<position position="3556"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA93625." ref="2" evidence="80">
<original>R</original>
<variation>G</variation>
<location>
<position position="3718"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA93625." ref="2" evidence="80">
<original>N</original>
<variation>D</variation>
<location>
<position position="3759"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA93625." ref="2" evidence="80">
<original>D</original>
<variation>G</variation>
<location>
<position position="3813"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58669." ref="1" evidence="80">
<original>A</original>
<variation>R</variation>
<location>
<position position="3901"/>
</location>
</feature>
<feature type="helix" evidence="18">
<location>
<begin position="114"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="25">
<location>
<begin position="140"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="150"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1151"/>
<end position="1154"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="1156"/>
<end position="1158"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="1159"/>
<end position="1162"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="1168"/>
<end position="1170"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="1171"/>
<end position="1175"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="1177"/>
<end position="1179"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1183"/>
<end position="1185"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="1190"/>
<end position="1192"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1197"/>
<end position="1200"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1204"/>
<end position="1206"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="1566"/>
<end position="1568"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="1570"/>
<end position="1572"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="1575"/>
<end position="1577"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1578"/>
<end position="1582"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="1585"/>
<end position="1587"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="1589"/>
<end position="1591"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="1594"/>
<end position="1596"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1597"/>
<end position="1599"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1604"/>
<end position="1612"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1614"/>
<end position="1617"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="1622"/>
<end position="1624"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="1627"/>
<end position="1629"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1631"/>
<end position="1652"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1655"/>
<end position="1661"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1708"/>
<end position="1716"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1723"/>
<end position="1740"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1745"/>
<end position="1765"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1771"/>
<end position="1773"/>
</location>
</feature>
<feature type="helix" evidence="24">
<location>
<begin position="2847"/>
<end position="2855"/>
</location>
</feature>
<feature type="helix" evidence="19">
<location>
<begin position="3764"/>
<end position="3766"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="3796"/>
<end position="3799"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="3809"/>
<end position="3811"/>
</location>
</feature>
<feature type="helix" evidence="22">
<location>
<begin position="3816"/>
<end position="3820"/>
</location>
</feature>
<feature type="helix" evidence="22">
<location>
<begin position="3823"/>
<end position="3830"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3831"/>
<end position="3835"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3837"/>
<end position="3847"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3854"/>
<end position="3857"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3860"/>
<end position="3864"/>
</location>
</feature>
<feature type="helix" evidence="22">
<location>
<begin position="3865"/>
<end position="3867"/>
</location>
</feature>
<feature type="helix" evidence="22">
<location>
<begin position="3868"/>
<end position="3877"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3884"/>
<end position="3886"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3888"/>
<end position="3894"/>
</location>
</feature>
<feature type="turn" evidence="22">
<location>
<begin position="3896"/>
<end position="3898"/>
</location>
</feature>
<feature type="helix" evidence="22">
<location>
<begin position="3901"/>
<end position="3904"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3912"/>
<end position="3920"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3923"/>
<end position="3932"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="3939"/>
<end position="3942"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J2S"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JYI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KKF"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KU7"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KYU"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LXS"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LXT"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MSR"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MTN"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W5Y"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W5Z"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EMH"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LQH"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LQI"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LQJ"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P4F"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3U85"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3U88"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ESG"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GQ6"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NW3"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F5E"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F6L"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SVH"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6EMQ"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P55200"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00155"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00190"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00509"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00875"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00876"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01146"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10490642"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12453419"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12482972"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14636557"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15199122"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15960975"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16253272"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16990798"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17467953"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17500065"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18829459"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18840606"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19187761"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19556245"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20010842"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20541251"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20677832"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21220120"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22327296"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22665483"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22795537"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22936661"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23178126"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23651431"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25082813"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25305204"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26886794"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29276034"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29997176"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8703835"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9537414"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="76" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10706619"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12453419"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1423625"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7598802"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000305"/>
<evidence key="81" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20677832"/>
</source>
</evidence>
<sequence length="3969" mass="431764" checksum="1150F37EAB1430D3" modified="2007-05-01" version="5">MAHSCRWRFPARPGTTGGGGGGGRRGLGGAPRQRVPALLLPPGPPVGGGGPGAPPSPPAVAAAAAAAGSSGAGVPGGAAAASAASSSSASSSSSSSSSASSGPALLRVGPGFDAALQVSAAIGTNLRRFRAVFGESGGGGGSGEDEQFLGFGSDEEVRVRSPTRSPSVKTSPRKPRGRPRSGSDRNSAILSDPSVFSPLNKSETKSGDKIKKKDSKSIEKKRGRPPTFPGVKIKITHGKDISELPKGNKEDSLKKIKRTPSATFQQATKIKKLRAGKLSPLKSKFKTGKLQIGRKGVQIVRRRGRPPSTERIKTPSGLLINSELEKPQKVRKDKEGTPPLTKEDKTVVRQSPRRIKPVRIIPSSKRTDATIAKQLLQRAKKGAQKKIEKEAAQLQGRKVKTQVKNIRQFIMPVVSAISSRIIKTPRRFIEDEDYDPPIKIARLESTPNSRFSAPSCGSSEKSSAASQHSSQMSSDSSRSSSPSVDTSTDSQASEEIQVLPEERSDTPEVHPPLPISQSPENESNDRRSRRYSVSERSFGSRTTKKLSTLQSAPQQQTSSSPPPPLLTPPPPLQPASSISDHTPWLMPPTIPLASPFLPASTAPMQGKRKSILREPTFRWTSLKHSRSEPQYFSSAKYAKEGLIRKPIFDNFRPPPLTPEDVGFASGFSASGTAASARLFSPLHSGTRFDMHKRSPLLRAPRFTPSEAHSRIFESVTLPSNRTSAGTSSSGVSNRKRKRKVFSPIRSEPRSPSHSMRTRSGRLSSSELSPLTPPSSVSSSLSISVSPLATSALNPTFTFPSHSLTQSGESAEKNQRPRKQTSAPAEPFSSSSPTPLFPWFTPGSQTERGRNKDKAPEELSKDRDADKSVEKDKSRERDREREKENKRESRKEKRKKGSEIQSSSALYPVGRVSKEKVVGEDVATSSSAKKATGRKKSSSHDSGTDITSVTLGDTTAVKTKILIKKGRGNLEKTNLDLGPTAPSLEKEKTLCLSTPSSSTVKHSTSSIGSMLAQADKLPMTDKRVASLLKKAKAQLCKIEKSKSLKQTDQPKAQGQESDSSETSVRGPRIKHVCRRAAVALGRKRAVFPDDMPTLSALPWEEREKILSSMGNDDKSSIAGSEDAEPLAPPIKPIKPVTRNKAPQEPPVKKGRRSRRCGQCPGCQVPEDCGVCTNCLDKPKFGGRNIKKQCCKMRKCQNLQWMPSKAYLQKQAKAVKKKEKKSKTSEKKDSKESSVVKNVVDSSQKPTPSAREDPAPKKSSSEPPPRKPVEEKSEEGNVSAPGPESKQATTPASRKSSKQVSQPALVIPPQPPTTGPPRKEVPKTTPSEPKKKQPPPPESGPEQSKQKKVAPRPSIPVKQKPKEKEKPPPVNKQENAGTLNILSTLSNGNSSKQKIPADGVHRIRVDFKEDCEAENVWEMGGLGILTSVPITPRVVCFLCASSGHVEFVYCQVCCEPFHKFCLEENERPLEDQLENWCCRRCKFCHVCGRQHQATKQLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYESKMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERHPAEWRLALEKELQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEFSDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIRQMERVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALWSAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATVGCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRRVFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGILNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINSTVEHDENRTIAHSPTSFTESSSKESQNTAEIISPPSPDRPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIVTVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPMRTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNLQRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSLKGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSSVSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSPDEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSFLEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVSSDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSKNALKESSPASPLQIESTSPTEPISASENPGDGPVAQPSPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSNMFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEGQVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQLDGVDDGTESDTSVTATTRKSSQIPKRNGKENGTENLKIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLESSRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGNILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEVFSQQLPTTEPVDSSVSSSISAEEQFELPLELPSDLSVLTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPEGHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLTRNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATEKLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPSVMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFPAATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQRTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLINFTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSIMYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSMQTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLIKASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTGITAASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLDSASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSASPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTSSSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPEVQVTQNPANEQESAEPKTVEEEESNFSSPLMLWLQQEQKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARLKQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNYKFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

